United Therapeutics | UTHR - Operating Expenses


United Therapeutics reported $6.59B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Amarin USD 51.37M 14.6M Sep/2025
Ardelyx USD 105.66M 6.4M Sep/2025
Baxter International USD 2.63B 95.8M Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
BioMarin Pharmaceutical USD 807.82M 259.3M Sep/2025
Gilead Sciences USD 4.26B 95M Sep/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
Halozyme Therapeutics USD 136.34M 13.06M Sep/2025
Insmed USD 403.69M 42.4M Sep/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Moderna USD 1.28B 232M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
PTC Therapeutics USD 207.52M 6.21M Sep/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Sarepta Therapeutics USD 462.23M 33.28M Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
United Therapeutics USD 6.59B 6.07B Sep/2025
Vertex Pharmaceuticals USD 1.84B 27.1M Sep/2025